CONVID-19

Coronavirus Reinfections Are Real but Very, Very Rare

 Apoorva Mandavilli

A case in Nevada has spurred new concerns that people who have recovered from the infection may still be vulnerable. That’s unlikely, experts say.

Reports of reinfection with the coronavirus evoke a nightmarish future: Repeat bouts of illness, impotent vaccines, unrelenting lockdowns — a pandemic without an end.

A case study published on Monday, about a 25-year-old man in Nevada, has stoked those fears anew. The man, who was not named, became sicker the second time that he was infected with the virus, a pattern the immune system is supposed to prevent.

People waited to be tested for coronavirus at Elmhurst Hospital Center in New York in March.Credit...John Minchillo/Associated Press

People waited to be tested for coronavirus at Elmhurst Hospital Center in New York in March.Credit...John Minchillo/Associated Press

But these cases make the news precisely because they are rare, experts said: More than 38 million people worldwide have been infected with the coronavirus, and as of Monday, fewer than five of those cases have been confirmed by scientists to be reinfections.

“That’s tiny — it’s like a microliter-sized drop in the bucket, compared to the number of cases that have happened all over the world,” said Angela Rasmussen, a virologist at Columbia University in New York.

In most cases, a second bout with the virus produced milder symptoms or none at all. But for at least three people, including one patient in Ecuador, the illness was more severe the second time around than during the first infection. An 89-year-old woman in the Netherlands died during her second illness.

Rare as these cases may be, they do indicate that reinfection is possible, said Akiko Iwasaki, an immunologist at Yale University, who wrote a commentary accompanying the Nevada case study, published in The Lancet Infectious Diseases.

“It’s important to note that there are people who do get reinfected, and in some of those cases you get worse disease,” Dr. Iwasaki said. “You still need to keep wearing masks and practice social distancing even if you have recovered once from this infection.”

We asked experts what is known about reinfections with the coronavirus, and what the phenomenon means for vaccinations and the course of the pandemic.

Reinfection with the coronavirus is an unusual event.

First, the good news: Reinfection seems to be vanishingly rare.

Since the first confirmed case of reinfection, reported in Hong Kong on Aug. 24, there have been three published cases; reports of another 20 await scientific review.

But it’s impossible to know exactly how widespread the phenomenon is. To confirm a case of reinfection, scientists must look for significant differences in the genes of the two coronaviruses causing both illnesses.

In the United States, where testing was a rare resource much of this year, many people were not tested unless they were sick enough to be hospitalized. Even then, their samples were usually not preserved for genetic analysis, making it impossible to confirm suspected reinfections.

A vast majority of people who do get reinfected may go undetected. For example, the man in Hong Kong had no symptoms the second time, and his infection was discovered only because of routine screening at the airport.

“There are a lot of people that are going to also have been exposed that aren’t having symptoms, that we’re never going to hear about,” said Marion Pepper, an immunologist at the University of Washington in Seattle.

People whose second infections are more severe are more likely to be identified, because they return to the hospital. But those are likely to be even rarer, experts said.

“If this was a very common event, we would have seen thousands of cases,” Dr. Iwasaki said.

In most people, the immune system works as expected.

Reinfections can occur for any number of reasons: because the initial infection was too mild to produce an immune response, for example, or because the immune system was compromised by other health conditions. On occasion, a patient may be exposed to a large amount of virus that seeded an infection before the immune response could respond.

This variability is entirely expected, experts said, and has been observed in patients with diseases like measles and malaria.

Initial Experience of an Emergency Department in Shenzhen in Responding to the Emerging Wuhan Coronavirus Pneumonia

Annals of Emergency Medicine
Volume 75, Issue 4, April 2020, Page 556.

Lu, K. L.; Chen, S.; Leung, L. P.

Since the emergence of a cluster of patients with pneumonia caused by a novel coronavirus (COVID-19) in Wuhan, Hubei, China, in December 2019, emergency departments (EDs) in China have instituted special measures to manage patients with potential exposure to the virus. We describe our initial experience in managing the current outbreak caused by COVID-19…

Keywords

Epidemiology

Science Education in the Era of a Pandemic

Science & Education

Erduran, Sibel.

In late February 2019, when the Covid-19 crisis began to spread across South Korea, my doctoral student Wonyong Park was there for his data collection in secondary schools. Unphased by the growing national epidemic at the time, he remarked: “As a Cambridge student, Newton once had to return home due to the plague outbreak in England, during which he made his greatest discoveries! However, as the situation develops, I promise I’ll keep healthy and make this time most useful for me.” Now, about a month later, the entire planet finds itself in the midst of a pandemic

Keywords

Epidemiology

Unprecedented Solutions for Extraordinary Times: Helping Long-Term Care Settings Deal with the COVID-19 Pandemic

Infection Control & Hospital Epidemiology

Gaur, Swati; Dumyati, Ghinwa; Nace, David A.; Jump, Robin L. P.

Our healthcare system faces an unprecedented strain as it struggles with the coronavirus disease 2019 (COVID-19) pandemic. With cases now reported in 53 states and territories, community spread is either already occurring or imminent in most localities. Most healthcare systems are experiencing limited access to diagnostic tests accompanied by delays in test results of more than 24 hours.1 Trials to assess potential treatments are underway, with mounting difficulty in acquiring agents as the demand for them increases.

Keywords

Clinical aspects, diagnosis, treatment

COVID-19 in Endoscopy: Time to do more?

Gastrointestinal Endoscopy

Thompson, Christopher C.; Shen, Lin; Lee, Linda S.

Introduction

We have read with great interest the paired articles on SARS-CoV-2/Novel Coronavirus19 (COVID-19) in this issue of Gastrointestinal Endoscopy. The first is entitled “Coronavirus (COVID-19) outbreak: what the department of endoscopy should know” by Repici et al, 1 which describes the Italian experience, and the second is “Considerations in performing endoscopy during the COVID-19 pandemic” by Soetikno et al, 2 which is drawn largely from the Hong Kong experience. We would like to congratulate the authors for their development and rigorous account of the endoscopic practices they have successfully used to minimize infection of endoscopy staff while providing essential services in this high-risk environment. We would also like to share a U.S. hospital perspective gained from our experience contending with numerous COVID-19 cases following the Biogen conference in Boston, Massachusetts.

Keywords

Clinical aspects, diagnosis, treatment

Knowledge And Attitudes Of Medical Staff In Chinese Psychiatric Hospitals Regarding COVID-19

Brain, Behavior, & Immunity - Health

Shi, Yudong; Wang, Juan; Yang, Yating; Wang, Zhiqiang; Wang, Guoqing; Hashimoto, Kenji; Zhang, Kai; Liu, Huanzhong.

Abstract

On March 11, 2020, the World Health Organization (WHO) declared the novel coronavirus COVID-19 a pandemic. There are patients in psychiatric hospitals in China who have been infected with COVID-19, however, the knowledge and attitudes of psychiatric hospital staff towards infectious diseases and their willingness to work during the COVID-19 outbreak has not yet been investigated. This study was performed to assess the knowledge and attitudes of medical staff in two Chinese mental health centers during the COVID-19 outbreak. We included 141 psychiatrists and 170 psychiatric nurses in the study. We found that during the COVID-19 epidemic, 89.51% of the medical staff of the psychiatric hospitals studied had extensive knowledge of COVID-19, and 64.63% of them received the relevant training in hospitals. Furthermore, about 77.17% of participants expressed a willingness to care for psychiatric patients suffering from COVID-19 virus infection. Independent predictors of willingness to care for patients included advanced training and experience of caring for patients with COVID-19. In conclusion, this study suggests that increased attention should be paid to the knowledge and attitudes of medical staff at psychiatric hospitals during the COVID-19 outbreak.

Keywords

COVID-19, Knowledge, Attitudes, Psychiatrists, Nurses

How could artificial intelligence aid in the fight against coronavirus?

Expert Review of Anti-infective Therapy

Yassine, Hadi M.; Shah, Zubair.

Do you believe that artificial intelligence (AI) is the key to a cure for the coronavirus?

Dr Hadi: Artificial intelligence (AI) is one of the means or avenues to understand the virus and develop preventative and control measures. This includes but is not limited to: the usage of mathematical modeling to understand virus transmission, structural biology to determine virus structure and develop vaccines, computational biology to understand virus evolution, as well as docking studies to screen for drugs and inhibitors

Keywords

COVID19, Artificial Intelligence, In-silico, Vaccines, Emerging Diseases

COVID-19, Diabetes Mellitus and ACE2: The Conundrum

Diabetes Research and Clinical Practice

Pal, Rimesh; Bhansali, Anil

Introduction

A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has scourged the world since its outbreak in December 2019 at Wuhan, China resulting in the World Health Organization declaring it as a pandemic. As of March 22, 2020, COVID-19 has affected over 292,000 people in at least 185 countries worldwide with most of the cases being reported from China, Europe and the United States of America. The absolute number of deaths has already surpassed 12,750 globally and is expected to increase further as the disease spreads rapidly. The disease has also infiltrated the Indian masses and is spreading fast. India being a developing nation with more than 1.3 billion people, failure to contain the virus can lead to disastrous consequences with death toll perhaps surpassing all other nations.

Keywords

Clinical aspects, diagnosis, treatment

Preventing bat-born viral outbreaks in future using ecological interventions

Environmental Research
Volume 185, June 2020, 109460

Nabi, Ghulam; Siddique, Rabeea; Ali, Ashaq; Khan, Suliman

Introduction

The Coronavirus Disease 2019 (COVID-19) outbreak caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported for the first time in December 2019, Wuhan, China (Khan et al., 2020). The COVID-19 then rapidly spread from the epicentre globally, and now characterized as a pandemic by the World Health Organization (World Health Organization, 2020). The high transmissibility of SARS-CoV-2, the lack of specific treatment and vaccines, and the unstoppable spread of infection have recently caused global health emergency, fear, and psychological stress among the public (Cohen and Kupferschmidt, 2020). Like SARS-CoV-2, other viruses including Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Marburg virus, and Ebola virus, have caused major outbreaks in history. These outbreaks caused large numbers of fatalities, morbidities, and cost billions of dollars, worldwide (Allocati et al., 2016; Fan et al., 2019). Bats are reported as a natural reservoir for these viruses, especially coronaviruses (CoVs) which constitute approximately, 31% of their virome (Allocati et al., 2016; Afelt et al., 2018). These viruses are transmitted to humans either directly or via intermediate hosts (Chan et al., 2013; Allocati et al., 2016). Furthermore, higher species diversity (over 1400), longer lifespan (over 30 years), resistance to viral infection, and migration make them a huge reservoir for pathogens and give them higher chances to transmit pathogens to other species in vast areas (Allocati et al., 2016; Frick et al., 2019; Banerjee et al., 2020). In 207 bat species, 5717 bat-associated animal viruses have been detected in 77 different countries (Allocati et al., 2016). However, the elusive and nocturnal habits make them difficult to be studied (Frick et al., 2019) therefore, there could be more deadly viruses with epidemic and pandemic potentials if other bats species are studied.

Keywords

Ethics, social science, economics

Can China return to normalcy while keeping the coronavirus in check?

Science

Normile, Dennis

.

Introduction

Life is almost back to normal in much of China. Shops, restaurants, bars, and offices are open for business. Manufacturing activity is picking up. Traffic once again jams the highways of major cities. Three quarters of China's workforce was back on the job as of 24 March, according to one company’s estimate. Wuhan, where the COVID-19 pandemic originated, is lagging, as is the rest of Hubei province but even there, the lockdown is due to lift 8 April. China has done what few believed was possible: bring a blazing epidemic of a respiratory virus to a virtual standstill. On 18 March, the country reported zero locally transmitted cases of COVID-19 for the first time. Since then, only 6 of such infections have been reported, only one of them in Wuhan. Now, the key question is: Can China keep it that way?

Keywords

Epidemiology

Iran confronts coronavirus amid a˜battle between science and conspiracy theories’

The European respiratory journal

Stone, Richard.

Introduction

When Mehdi Variji fell ill with COVID-19 in early March, he holed up in his apartment in Tehran, Iran, to ride it out. The comforts of home didn’t seem to help. As he grew short of breath and oxygen levels in his blood ebbed, Variji, a 43-year-old physician who ran Tehran’s 21st District Clinic, knew he faced a bleak prognosis. “I’m taking three medicines, but they are not working on me,” he said in a cellphone video he shot a few days before his death. A somber cellphone video shot on 20 March shows four gowned and masked workers preparing his grave in the courtyard of a shrine in his hometown, Sari. His wife and children stayed away because of the infection risk. It was just after midnight on Nowruz, the first day of the Persian new year and normally the beginning of a joyous festival.

Keywords

COVID-19, SARS-CoV-2, Treatment

Covid-19: Doctors Are Told Not To Perform CPR On Patients In Cardiac Arrest

BMJ
Volume 368, 2020, m1282-m1282

Mahase, Elisabeth; Kmietowicz, Zosia.

Introduction

Healthcare staff in the West Midlands have been told not to start chest compressions or ventilation in patients who are in cardiac arrest if they have suspected or diagnosed covid-19 unless they are in the emergency department and staff are wearing full personal protective equipment (PPE).

The guidance from the University Hospitals Birmingham NHS Foundation Trust says that patients in cardiac arrest outside the emergency department can be given defibrillator treatment if they have a “shockable” rhythm. But if this fails to restart the heart “further resuscitation is futile,” it says.

Keywords

COVID-19, SARS-CoV-2, Treatment

COVID-19 and the Otolaryngologist - Preliminary Evidence-Based Review

The Laryngoscope

Vukkadala, Neelaysh; Qian, Z. Jason; Holsinger, F. Christopher; Patel, Zara M.; Rosenthal, Eben.

Abstract

The SARS-CoV-2 virus which causes coronavirus disease 2019 (COVID-19) has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID-19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University. This article is protected by copyright. All rights reserved.

Keywords

COVID-19; SARS-CoV-2; clinical practice guidelines; evidence-based medicine; infectious disease.

Neurosurgery During The COVID-19 Pandemic: Update From Lombardy, Northern Italy

Acta Neurochirurgica

Zoia, Cesare; Bongetta, Daniele; Veiceschi, Pierlorenzo; Cenzato, Marco; Di Meco, Francesco; Locatelli, Davide; Boeris, Davide; Fontanella, Marco M.

Introduction

Since February, 21st 2020, when the first person infected was reported in Lombardy, Italy rapidly became home to a massive Coronavirus Disease 2019 (COVID-19) outbreak. Currently, on 21th March, 53,578 COVID-19 cases have been confirmed in Italy. 6072 patients are now hospitalized. The number of deaths has risen to 4825 while 6072 were declared healed [4]. This data shows that Italy is, currently, the second most affected nation in the world by the epidemic, second only to China

Keywords

RCT; Clinical aspects, diagnosis, treatment

Learning From History: Coronavirus Outbreaks In The Past

Dermatologic Therapy

Abdelmaksoud, Ayman; Kroumpouzos, George; Jafferany, Mohammad; Lotti, Torello; Sadoughifar, Roxanna; Goldust, Mohamad

Introduction

“Those who cannot remember the past are condemned to repeat it." -George Santayana
Coronaviruses were considered relatively harmless pathogens until they caused three major outbreaks of severe respiratory disease in the last 20 years. The current pandemic has compelled us to scrutinize the break-outs that have occurred in the past and imposed global threat time and again. Coronavirus is a single stranded enveloped RNA virus that belongs to the subfamily Coronavirinae. Based on the genomic structure, 4 subtypes of this zoonotic virus have been recognized- alphacoronavirus, betacoronavirus, gammacoronavirus and delta coronavirus. Alphacoronavirus and beta coronaviruses infect only mammals whereas gammacoronavirus and delta coronavirus infect mainly birds. Out of the former group, seven viruses are known to cause human disease. Four of these viruses, HCoV 229E, HCoV OC43, HCoVNL63 and HCoVHKU1, cause mild infections whereas three, SARS-CoV, MERS-CoV and the recently identified SARS-CoV2 cause serious respiratory illnesses in humans (Marra et al., 2003).

Keywords

Epidemiology

World In Lockdown

New Scientist
Volume 245, Issue 3275, March 2020, Page 7

Hamzelou, Jessica

Introduction

Around a fifth of the global population is in lockdown as COVID-19 cases continue to rise, reports Jessica Hamzelou.


HE covid-19 pandemic is speeding up, the World Health Organization's director general has warned. As New Scientist went to press, 382,000 cases of the disease had been confirmed, although the actual number is likely to be much higher. More than 16,500 people have died.

Keywords

Epidemiology

Do You Become Immune Once You Have Been Infected?

New Scientist
Volume 245, Issue 3275, 28 March 2020, Pages 10-11

GI.

Introduction

SAY you have caught COVID-19 and recovered – are you now immune for life, or could you catch it again? We just don't know yet.

In February, reports emerged of a woman in Japan who had been given the all-clear after having COVID-19 but then tested positive for the SARS-CoV-2 virus a second time. There have also been reports of a man in Japan testing positive after being given the all-clear, and anecdotal cases of second positives have emerged from China, too.

Keywords

Epidemiology

Arthralgia as an initial presentation of COVID-19: observation

Rheumatology International

Joob, Beuy; Wiwanitkit, Viroj.

Dear Editor,

Arthralgia is an important clinical complaint seen in many virus infections. For a new emerging disease from China, COVID-19, the data on the rheumatic manifestation are limited. In a clinical epidemiology report published in Lancet, no data on joint complaint of the patients are mentioned. Here, the authors would like to share observation from Thailand, the second country where the disease exists. In Thailand, at present (28 February 2020), there are 40 patients. Of these 40 patients, at least one patient (2.5%) presented with joint pain complaint. The case is a female patient who initially presented with high fever and low platelet count was observed…

Keywords

COVID-19, SARS-CoV-2, Treatment